A pt, (b)(6) was enrolled to the coaptite injectable implant study for stress urinary incontinence.The pt was injected with 1.0 ml of coaptite lot #1034459 on (b)(6) 2012.The pt reported swelling on (b)(6) 2012 which was reported due to the coaptite injection.The pt went to the er and was treated with foley catheterization.The swelling resolved on (b)(6) 2012.The physician assessed the event as mild in severity and definitely device related.On (b)(6) 2012 the pt reported urge incontinence.On (b)(6) 2012, the pt was treated with anticholinergic topical gelnique.Resolution date was not reported.The physician assessed the event as mild in severity and definitely not device related.
|